CRISPR Screens Reveal Oncogenic lncRNAs Targeted by CDK4/6 Inhibitors
In the ever-evolving landscape of cancer research, the discovery of novel therapeutic targets remains a paramount priority. Recently, a groundbreaking ...
Tag: CDK4/6 inhibitors in oncology
Abemaciclib and Fulvestrant: Real-World vs MONARCH-2
In a groundbreaking study published recently in the British Journal of Cancer, researchers have provided compelling real-world evidence on the ...
Palbociclib vs. Ribociclib: Indian Breast Cancer Study
In a groundbreaking study emerging from India, researchers have conducted a meticulous head-to-head comparison of two prominent cyclin-dependent kinase 4/6 ...
-
Mothers who receive childcare support from maternal grandparents show more parental warmth, finds NTU Singapore study
-
University of Seville Breaks 120-Year-Old Mystery, Revises a Key Einstein Concept
-
Bee body mass, pathogens and local climate influence heat tolerance
-
Researchers record first-ever images and data of a shark experiencing a boat strike
-
Groundbreaking Clinical Trial Reveals Lubiprostone Enhances Kidney Function
Embark on a thrilling journey of discovery with Scienmag.com—your ultimate source for cutting-edge breakthroughs. Immerse yourself in a world where curiosity knows no limits and tomorrow’s possibilities become today’s reality!